Liminatus Pharma, Inc. Warrants
Liminatus Pharma, Inc. Warrants
- Market cap
- $1.00M
Your view on LIMNW
Overview
What the company does, where it operates, and who runs it.
About Liminatus Pharma, Inc. Warrants
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chris Kim
- Headquarters
- 12611 Hiddencreek Way, Cerritos, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Chris Kim
- Headquarters
- 12611 Hiddencreek Way, Cerritos, CA, US
Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Liminatus Pharma, Inc. Warrants. Starting points for Liminatus Pharma, Inc. Warrants: EPS -$26.36, beta 0.74 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Liminatus Pharma, Inc. Warrants. Trailing twelve-month EPS for Liminatus Pharma, Inc. Warrants stands at -$26.36. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Liminatus Pharma, Inc. Warrants. Liminatus Pharma, Inc. Warrants has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| BICTFBiocure Technology Inc. | Healthcare | OTC | $379,088 | ||
| BIOABioAge Labs, Inc. | Healthcare | NASDAQ | $161.1M | ||
| BIOAFBioasis Technologies Inc. | Healthcare | OTC | $15,883 | ||
| BIORQBiora Therapeutics, Inc. | Healthcare | PNK | — | ||
| BIT.AXBiotron Limited | Healthcare | ASX | — | ||
| BITRFBiotron Limited | Healthcare | OTC | $29.2M | ||
| BIVIBioVie Inc. | Healthcare | NASDAQ | $8.6M | ||
| BIXTBioxytran, Inc. | Healthcare | OTC | $3.6M | ||
| BLAB.CNBritannia Life Sciences Inc. | Healthcare | CNQ | $13.0M | ||
| BLEGBranded Legacy Inc | Healthcare | OTC | $542,622 | ||
| BLRXBioLineRx Ltd. | Healthcare | NASDAQ | $4.8M | ||
| BLSMBlossomHill Therapeutics, Inc. | Healthcare | NASDAQ | $422.0M | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Liminatus Pharma, Inc. Warrants executives and directors. Shares of Liminatus Pharma, Inc. Warrants have traded between $0.07 and $0.07 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Liminatus Pharma, Inc. Warrants. Coverage tracks Liminatus Pharma, Inc. Warrants within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Liminatus Pharma, Inc. Warrants.